{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:58:39Z","timestamp":1794405519593,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-105-2628-B-006-016-MY3 and MOST-106-2628-B-006-001-MY4"],"award-info":[{"award-number":["MOST-105-2628-B-006-016-MY3 and MOST-106-2628-B-006-001-MY4"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Currently there are no therapies for treating Alzheimer\u2019s disease (AD) that can effectively halt disease progression. Existing drugs such as acetylcholinesterase inhibitors or NMDA receptor antagonists offers only symptomatic benefit. More recently, transplantation of neural stem cells (NSCs) to treat neurodegenerative diseases, including AD, has been investigated as a new therapeutic approach. Transplanted cells have the potential to replace damaged neural circuitry and secrete neurotrophic factors to counter symptomatic deterioration or to alter lesion protein levels. However, since there are animal models that can recapitulate AD in its entirety, it is challenging to precisely characterize the positive effects of transplanting NSCs. In the present review, we discuss the types of mouse modeling system that are available and the effect in each model after human-derived NSC (hNSC) or murine-derived NSC (mNSC) transplantation. Taken together, results from studies involving NSC transplantation in AD models indicate that this strategy could serve as a new therapeutic approach.<\/jats:p>","DOI":"10.1186\/s12929-020-0622-x","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T18:03:38Z","timestamp":1580148218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Effects of neural stem cell transplantation in Alzheimer\u2019s disease models"],"prefix":"10.1186","volume":"27","author":[{"given":"Yoshihito","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Che","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-9735","authenticated-orcid":false,"given":"Kuen-Jer","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"issue":"Pt 12","key":"622_CR1","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/brain\/awv316","volume":"138","author":"NS Ryan","year":"2015","unstructured":"Ryan NS, Rossor MN, Fox NC. Alzheimer's disease in the 100 years since Alzheimer's death. Brain. 2015;138(Pt 12):3816\u201321.","journal-title":"Brain"},{"key":"622_CR2","unstructured":"Wenk, G.L., Neuropathologic changes in ALzheimers Disease. The Journal of Clinical Psychiatry, 2003. 64(Suppl 9:7\u201310)."},{"issue":"10","key":"622_CR3","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.7150\/ijbs.35743","volume":"15","author":"R Guan","year":"2019","unstructured":"Guan R, et al. Trends in Alzheimer's disease research based upon machine learning analysis of PubMed abstracts. Int J Biol Sci. 2019;15(10):2065\u201374.","journal-title":"Int J Biol Sci"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(99)00861-7","volume":"277","author":"BD Gerwin Roksa","year":"1999","unstructured":"Gerwin Roksa BD, Heutinkc P, Julliamsb A, Backhovensb H, Van de Broeckb M, Serneelsb S, Hofmana A, Van Broeckhovenb C, van Duijna CM, Crutsb M. Mutation screening of the tau gene in patients with early-onset. Neurosci Lett. 1999;277:137\u20139.","journal-title":"Neurosci Lett"},{"issue":"9","key":"622_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7(9):940\u20136.","journal-title":"EMBO Rep"},{"issue":"9","key":"622_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, et al. APPsw transgenic mice develop age-related A\u03b2 deposits and Neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol. 1997;56(9):965\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"622_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, et al. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy. Mol Neurodegener. 2016;11(1):39.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"622_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","volume":"16","author":"R Briggs","year":"2016","unstructured":"Briggs R, Kennelly SP, O'Neill D. Drug treatments in Alzheimer\u2019s disease. Clin Med. 2016;16(3):247\u201353.","journal-title":"Clin Med"},{"key":"622_CR9","first-page":"106","volume":"36","author":"MF Hari Manev","year":"1989","unstructured":"Hari Manev MF. Alessandro Guidotti, and Erminio Costa, Delayed Increase of Ca2\u0131 Influx Elicited by Glutamate: Role in Neuronal Death. Mol Pharmacol. 1989;36:106\u201312.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"622_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Neuropharmacology. 2007;53(6):699\u2013723.","journal-title":"Neuropharmacology"},{"issue":"1","key":"622_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13195-015-0109-2","volume":"7","author":"A Atri","year":"2015","unstructured":"Atri A, et al. Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis. Alzheimers Res Ther. 2015;7(1):28.","journal-title":"Alzheimers Res Ther"},{"key":"622_CR12","unstructured":"David A. Casey, D.A., James O\u2019Brien, Drugs for Alzheimer\u2019s Disease Are They Effective 2010. 35(4)."},{"issue":"7","key":"622_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2146\/news150026","volume":"72","author":"K Traynor","year":"2015","unstructured":"Traynor K. Effective drug therapy for Alzheimer's disease remains elusive. Am J Health Syst Pharm. 2015;72(7):516 518.","journal-title":"Am J Health Syst Pharm"},{"key":"622_CR14","doi-asserted-by":"publisher","unstructured":"Morris GP, Clark IA, Vissel B. Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease. Acta Neuropathol Commun. 2014;2(135). https:\/\/doi.org\/10.1186\/s40478-014-0135-5.","DOI":"10.1186\/s40478-014-0135-5"},{"issue":"4","key":"622_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4161\/hv.28183","volume":"10","author":"A Fettelschoss","year":"2014","unstructured":"Fettelschoss A, Zabel F, Bachmann MF. Vaccination against Alzheimer disease. Human Vaccines Immunother. 2014;10(4):847\u201351.","journal-title":"Human Vaccines Immunother"},{"issue":"1","key":"622_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/wsbm.100","volume":"3","author":"KB Massirer","year":"2011","unstructured":"Massirer KB, et al. Maintenance and differentiation of neural stem cells. Wiley Interdiscip Rev Syst Biol Med. 2011;3(1):107\u201314.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"5","key":"622_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","volume":"9","author":"PL Martinez-Morales","year":"2013","unstructured":"Martinez-Morales PL, et al. Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev. 2013;9(5):685\u201399.","journal-title":"Stem Cell Rev"},{"key":"622_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ymeth.2017.09.007","volume":"133","author":"E Shahbazi","year":"2018","unstructured":"Shahbazi E, et al. Reprogramming of somatic cells to induced neural stem cells. Methods. 2018;133:21\u20138.","journal-title":"Methods"},{"issue":"Suppl 1","key":"622_CR19","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1007\/s00702-013-1042-9","volume":"120","author":"A Hermann","year":"2013","unstructured":"Hermann A, Storch A. Induced neural stem cells (iNSCs) in neurodegenerative diseases. J Neural Transm (Vienna). 2013;120(Suppl 1):S19\u201325.","journal-title":"J Neural Transm (Vienna)"},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jbiotec.2014.07.453","volume":"188","author":"Y Wen","year":"2014","unstructured":"Wen Y, Jin S. Production of neural stem cells from human pluripotent stem cells. J Biotechnol. 2014;188:122\u20139.","journal-title":"J Biotechnol"},{"issue":"11","key":"622_CR21","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/nprot.2012.123","volume":"7","author":"W Guo","year":"2012","unstructured":"Guo W, et al. Isolation of multipotent neural stem or progenitor cells from both the dentate gyrus and subventricular zone of a single adult mouse. Nat Protoc. 2012;7(11):2005\u201312.","journal-title":"Nat Protoc"},{"key":"622_CR22","unstructured":"Lee, J.P., et al., Neural stem cell transplantation in mouse brain. Curr Protoc Neurosci, 2008. Chapter 3: p. Unit 3 10."},{"issue":"32","key":"622_CR23","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"MK Mathew Blurton-Jones","year":"2009","unstructured":"Mathew Blurton-Jones MK, Martinez-coria H, Nicholas A, Castello F-JM, Loring TRYJF, Poon WW, Green KN, LaFerla FM. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. PNAS. 2009;106(32):13594\u20139.","journal-title":"PNAS"},{"key":"622_CR24","doi-asserted-by":"publisher","unstructured":"Parmar M. Towards stem cell based therapies for Parkinson's disease. Development. 2018;145(1). https:\/\/doi.org\/10.1242\/dev.156117.","DOI":"10.1242\/dev.156117"},{"key":"622_CR25","first-page":"571475","volume":"2015","author":"CH Chou","year":"2015","unstructured":"Chou CH, Fan HC, Hueng DY. Potential of neural stem cell-based therapy for Parkinson's disease. Parkinsons Dis. 2015;2015:571475.","journal-title":"Parkinsons Dis"},{"key":"622_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymeth.2017.08.017","volume":"133","author":"KA Choi","year":"2018","unstructured":"Choi KA, Choi Y, Hong S. Stem cell transplantation for Huntington's diseases. Methods. 2018;133:104\u201312.","journal-title":"Methods"},{"issue":"2","key":"622_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15283\/ijsc.2009.2.2.102","volume":"2","author":"S-TL Wooseok Im","year":"2009","unstructured":"Wooseok Im S-TL. Kon Chu, Manho Kim, Jae-Kyu Roh, Stem Cells Transplantation and Huntington\u2019s Disease. Int J Stem Cells. 2009;2(2):102\u20138.","journal-title":"Int J Stem Cells"},{"key":"622_CR28","doi-asserted-by":"crossref","unstructured":"Edwards, A., Neural stem cell transplantation in ALS: developing a cure for the incurable? Bioscience Horizons 2016. 9(2016).","DOI":"10.1093\/biohorizons\/hzw013"},{"issue":"2","key":"622_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/1673-5374.152361","volume":"10","author":"M Telias","year":"2015","unstructured":"Telias M, Ben-Yosef D. Neural stem cell replacement: a possible therapy for neurodevelopmental disorders? Neural Regen Res. 2015;10(2):180\u20132.","journal-title":"Neural Regen Res"},{"issue":"2","key":"622_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neures.2008.06.005","volume":"62","author":"J Tang","year":"2008","unstructured":"Tang J, et al. Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats. Neurosci Res. 2008;62(2):86\u201396.","journal-title":"Neurosci Res"},{"issue":"4","key":"622_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3892\/mmr.2014.2393","volume":"10","author":"F Liu","year":"2014","unstructured":"Liu F, et al. Combined effect of nerve growth factor and brainderived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol Med Rep. 2014;10(4):1739\u201345.","journal-title":"Mol Med Rep"},{"key":"622_CR32","doi-asserted-by":"publisher","first-page":"27358","DOI":"10.1038\/srep27358","volume":"6","author":"CC Wu","year":"2016","unstructured":"Wu CC, et al. Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease. Sci Rep. 2016;6:27358.","journal-title":"Sci Rep"},{"issue":"1","key":"622_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41598-017-18542-0","volume":"8","author":"DH Kim","year":"2018","unstructured":"Kim DH, et al. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model. Sci Rep. 2018;8(1):354.","journal-title":"Sci Rep"},{"key":"622_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2017.02.006","volume":"106","author":"SE Marsh","year":"2017","unstructured":"Marsh SE, Blurton-Jones M. Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support. Neurochem Int. 2017;106:94\u2013100.","journal-title":"Neurochem Int"},{"issue":"5","key":"622_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nbt.2565","volume":"31","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat Biotechnol. 2013;31(5):440\u20137.","journal-title":"Nat Biotechnol"},{"issue":"44","key":"622_CR36","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.1523\/JNEUROSCI.1627-07.2007","volume":"27","author":"TR Yamasaki","year":"2007","unstructured":"Yamasaki TR, et al. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci. 2007;27(44):11925\u201333.","journal-title":"J Neurosci"},{"key":"622_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13041-015-0110-5","volume":"8","author":"L Devi","year":"2015","unstructured":"Devi L, Ohno M. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Mol Brain. 2015;8:19.","journal-title":"Mol Brain"},{"issue":"1","key":"622_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord. 2013;6(1):19\u201333.","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"622_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nrn1116","volume":"4","author":"PB Tran","year":"2003","unstructured":"Tran PB, Miller RJ. Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci. 2003;4(6):444\u201355.","journal-title":"Nat Rev Neurosci"},{"key":"622_CR40","first-page":"6392986","volume":"2018","author":"KA Kwak","year":"2018","unstructured":"Kwak KA, et al. Current perspectives regarding stem cell-based therapy for Alzheimer's disease. Stem Cells Int. 2018;2018:6392986.","journal-title":"Stem Cells Int"},{"issue":"3","key":"622_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles. Neuron. 2003;39(3):409\u201321.","journal-title":"Neuron"},{"issue":"5","key":"622_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, et al. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron. 2005;45(5):675\u201388.","journal-title":"Neuron"},{"issue":"7","key":"622_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hipo.22405","volume":"25","author":"RR Ager","year":"2015","unstructured":"Ager RR, et al. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus. 2015;25(7):813\u201326.","journal-title":"Hippocampus"},{"issue":"2","key":"622_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/1533317513506776","volume":"29","author":"SQ Chen","year":"2014","unstructured":"Chen SQ, et al. Neural stem cell transplantation improves spatial learning and memory via neuronal regeneration in amyloid-beta precursor protein\/presenilin 1\/tau triple transgenic mice. Am J Alzheimers Dis Other Dement. 2014;29(2):142\u20139.","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"622_CR45","doi-asserted-by":"publisher","unstructured":"Mathew Blurton-Jones BS, Michael S, Castello NA, Agazaryan AA, Davis JL, M\u00fcller JFLF-J, Masliah E, LaFerla FM, Blurton-Jones, et al. Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res Ther. 2014;5(46). https:\/\/doi.org\/10.1186\/scrt440.","DOI":"10.1186\/scrt440"},{"key":"622_CR46","doi-asserted-by":"publisher","unstructured":"Byrne JA. Developing neural stem cell-based treatments for neurodegenerative diseases. Byrne Stem Cell Res Ther. 2014;5(72). https:\/\/doi.org\/10.1186\/scrt461.","DOI":"10.1186\/scrt461"},{"key":"622_CR47","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0031-9384(02)00639-X","volume":"75","author":"DL King","year":"2002","unstructured":"King DL, Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer\u2019s disease through 19 months. Physiol Behav. 2002;75:627\u201342.","journal-title":"Physiol Behav"},{"issue":"2","key":"622_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi T, et al. Age-dependent changes in brain, CSF, and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001;21(2):372\u201381.","journal-title":"J Neurosci"},{"issue":"5284","key":"622_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, et al. Correlative memory deficits, a elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99\u2013103.","journal-title":"Science"},{"key":"622_CR50","doi-asserted-by":"publisher","first-page":"370432","DOI":"10.1155\/2015\/370432","volume":"2015","author":"AM Lilja","year":"2015","unstructured":"Lilja AM, et al. Neural stem cell transplant-induced effect on neurogenesis and cognition in Alzheimer Tg2576 mice is inhibited by concomitant treatment with amyloid-lowering or cholinergic alpha7 nicotinic receptor drugs. Neural Plast. 2015;2015:370432.","journal-title":"Neural Plast"},{"key":"622_CR51","doi-asserted-by":"publisher","first-page":"e1789","DOI":"10.1038\/cddis.2015.138","volume":"6","author":"JA Kim","year":"2015","unstructured":"Kim JA, et al. Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model. Cell Death Dis. 2015;6:e1789.","journal-title":"Cell Death Dis"},{"issue":"5","key":"622_CR52","first-page":"194","volume":"17","author":"LF Maia","year":"2013","unstructured":"Maia LF, Kaeser SA, Reichwald J, Hruscha M, Martus P, Staufenbiel M, Jucker M. Changes in Amyloid-b and Tau in the Cerebrospinal Fluid of Transgenic Mice overexpressing Amyloid Precursor Protein. Sci Transl Med. 2013;17(5):194.","journal-title":"Sci Transl Med"},{"key":"622_CR53","first-page":"282","volume":"8","author":"X Li","year":"2016","unstructured":"Li X, et al. Human neural stem cell transplantation rescues cognitive defects in APP\/PS1 model of Alzheimer's disease by enhancing neuronal connectivity and metabolic activity. Front Aging Neurosci. 2016;8:282.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"622_CR54","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","volume":"8","author":"LM McGinley","year":"2018","unstructured":"McGinley LM, et al. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer's disease. Sci Rep. 2018;8(1):14776.","journal-title":"Sci Rep"},{"key":"622_CR55","doi-asserted-by":"publisher","first-page":"3106980","DOI":"10.1155\/2016\/3106980","volume":"2016","author":"H Haiyan","year":"2016","unstructured":"Haiyan H, et al. Effect of Astragaloside IV on neural stem cell transplantation in Alzheimer's disease rat models. Evid Based Complement Alternat Med. 2016;2016:3106980.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"622_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jnr.23299","volume":"92","author":"W Zhang","year":"2014","unstructured":"Zhang W, et al. Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease. J Neurosci Res. 2014;92(2):185\u201394.","journal-title":"J Neurosci Res"},{"issue":"3","key":"622_CR57","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.neurobiolaging.2014.10.040","volume":"36","author":"W Zhang","year":"2015","unstructured":"Zhang W, et al. Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer's disease-like pathology. Neurobiol Aging. 2015;36(3):1282\u201392.","journal-title":"Neurobiol Aging"},{"key":"622_CR58","doi-asserted-by":"crossref","unstructured":"Zhang Q, et al. Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer's disease. J Neurochem. 2015.","DOI":"10.1111\/jnc.13413"},{"key":"622_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuroscience.2015.01.073","volume":"291","author":"G Gu","year":"2015","unstructured":"Gu G, et al. Transplantation of NSC-derived cholinergic neuron-like cells improves cognitive function in APP\/PS1 transgenic mice. Neuroscience. 2015;291:81\u201392.","journal-title":"Neuroscience"},{"issue":"2","key":"622_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12035-014-8640-x","volume":"50","author":"W Zhang","year":"2014","unstructured":"Zhang W, et al. Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP\/PS1 double transgenic model of Alzheimer's disease. Mol Neurobiol. 2014;50(2):423\u201337.","journal-title":"Mol Neurobiol"},{"issue":"40","key":"622_CR61","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"622_CR62","doi-asserted-by":"publisher","first-page":"196 e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, et al. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2012;33(1):196 e29\u201340.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"622_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stemcr.2016.12.019","volume":"8","author":"SE Marsh","year":"2017","unstructured":"Marsh SE, et al. HuCNS-SC human NSCs fail to differentiate, form ectopic clusters, and provide no cognitive benefits in a transgenic model of Alzheimer's disease. Stem Cell Reports. 2017;8(2):235\u201348.","journal-title":"Stem Cell Reports"},{"issue":"6","key":"622_CR64","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.stemcr.2019.10.012","volume":"13","author":"T Zhang","year":"2019","unstructured":"Zhang T, et al. Human neural stem cells reinforce hippocampal synaptic network and rescue cognitive deficits in a mouse model of Alzheimer's disease. Stem Cell Reports. 2019;13(6):1022\u201337.","journal-title":"Stem Cell Reports"},{"key":"622_CR65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, et al. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"8","key":"622_CR66","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","volume":"21","author":"T Kondo","year":"2017","unstructured":"Kondo T, et al. iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid beta combination for Alzheimer's disease. Cell Rep. 2017;21(8):2304\u201312.","journal-title":"Cell Rep"},{"issue":"23","key":"622_CR67","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi T, et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20(23):4530\u20139.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"622_CR68","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"CR Muratore","year":"2014","unstructured":"Muratore CR, et al. The familial Alzheimer's disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons. Hum Mol Genet. 2014;23(13):3523\u201336.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"622_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3727\/096368915X688614","volume":"25","author":"K Bernau","year":"2016","unstructured":"Bernau K, et al. In vivo tracking of human neural progenitor cells in the rat brain using magnetic resonance imaging is not enhanced by ferritin expression. Cell Transplant. 2016;25(3):575\u201392.","journal-title":"Cell Transplant"},{"key":"622_CR70","doi-asserted-by":"publisher","first-page":"2934149","DOI":"10.1155\/2017\/2934149","volume":"2017","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, et al. Stem cell tracking Technologies for Neurological Regenerative Medicine Purposes. Stem Cells Int. 2017;2017:2934149.","journal-title":"Stem Cells Int"},{"issue":"3\u20134","key":"622_CR71","first-page":"181","volume":"2","author":"OR Yabut","year":"2016","unstructured":"Yabut OR, Pleasure SJ. The crossroads of neural stem cell development and tumorigenesis. Opera Med Physiol. 2016;2(3\u20134):181\u20137.","journal-title":"Opera Med Physiol"},{"key":"622_CR72","doi-asserted-by":"crossref","unstructured":"Doo-Sik, K., Cancer stem cells in brain tumors and their lineage hierarchy. International Journal of Stem Cells 2012. 5 (1).","DOI":"10.15283\/ijsc.2012.5.1.12"},{"issue":"1","key":"622_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12015-015-9622-8","volume":"12","author":"M Brouwer","year":"2016","unstructured":"Brouwer M, Zhou H, Nadif Kasri N. Choices for induction of Pluripotency: recent developments in human induced pluripotent stem cell reprogramming strategies. Stem Cell Rev Rep. 2016;12(1):54\u201372.","journal-title":"Stem Cell Rev Rep"},{"key":"622_CR74","doi-asserted-by":"publisher","first-page":"e4370","DOI":"10.7717\/peerj.4370","volume":"6","author":"AE Omole","year":"2018","unstructured":"Omole AE, Fakoya AOJ. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ. 2018;6:e4370.","journal-title":"PeerJ"},{"issue":"7618","key":"622_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer's disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"key":"622_CR76","doi-asserted-by":"crossref","unstructured":"Howard, R. and K.Y. Liu, Questions EMERGE as Biogen claims aducanumab turnaround. Nat Rev Neurol, 2019.","DOI":"10.1038\/s41582-019-0295-9"},{"key":"622_CR77","unstructured":"Schneider, L., A resurrection of aducanumab for Alzheimer's disease. The Lancet Neurology, 2019."},{"issue":"4","key":"622_CR78","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, et al. Trial of Solanezumab for mild dementia due to Alzheimer's disease. N Engl J Med. 2018;378(4):321\u201330.","journal-title":"N Engl J Med"},{"issue":"10","key":"622_CR79","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019;29(10):787\u2013803.","journal-title":"Cell Res"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-0622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-020-0622-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-0622-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:09:57Z","timestamp":1611619797000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-020-0622-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/s12929-020-0622-x","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"10 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}